CLEVELAND (AP) — CLEVELAND (AP) — Abeona Therapeutics Inc. (ABEO) on Wednesday reported a loss of $17.1 million in its first quarter. The Cleveland-based company said it had a loss of 30 cents per share. The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 33 cents per share. The drug developer posted revenue of $8.7 million in the period, which also topped Stree…